Back |
home / stock / omed / omed message board
Subject | By | Source | When |
---|---|---|---|
NEWS | subslover | investorshub | 09/12/2022 1:01:23 PM |
$Mereo BioPharma Sends Letter to Rubric Capital $Management | subslover | investorshub | 08/31/2022 3:39:24 PM |
They want out with the old and in | subslover | investorshub | 08/22/2022 10:45:44 PM |
Mereo BioPharma Sends Letter to Rubric Capital Management (8/22/22) | Enterprising Investor | investorshub | 08/22/2022 8:42:51 PM |
Lots of good action yesterday! Closed Up 18% | subslover | investorshub | 08/13/2022 1:44:31 PM |
Mereo BioPharma Group plc (NASDAQ:$MREO) went up by | subslover | investorshub | 07/18/2022 11:19:18 AM |
PRE MARKET $1.91 | subslover | investorshub | 07/18/2022 11:15:28 AM |
Next stop 2.00 then 2.26 | TrendTrade2016 | investorshub | 07/16/2022 12:34:24 PM |
Excellent forensic analysis for sure! Thank you for | subslover | investorshub | 07/16/2022 12:05:11 AM |
Its been a month. | Enterprising Investor | investorshub | 07/15/2022 1:49:38 PM |
Closed @ 1.63 post-market only .20 off your | subslover | investorshub | 07/15/2022 12:12:55 AM |
Inching higher all week. Could get very exciting! :) | subslover | investorshub | 07/14/2022 1:23:22 AM |
Another nice one. LMAO | The-REAL-KING-of-pennies | investorshub | 07/13/2022 1:27:45 PM |
whytestocks: $OMED News Article - Mereo BioPharma Group plc (Mereo or the Company or the Group) Merg | whytestocks | investorshangout | 04/18/2019 12:20:44 PM |
znewcar1: 18% v3,3M c.9910 f38,690,089 H1.08 gap dip and rip | znewcar1 | investorshangout | 03/16/2019 1:49:28 AM |
whytestocks: $OMED News Article - OncoMed Pharmaceuticals Declares Special Dividend of Contingent Va | whytestocks | investorshangout | 03/15/2019 12:30:41 PM |
znewcar1: 15.96% v4,218,771 c.8923 f38,630,145 was going sideways until lunch then .8 to >.95 | znewcar1 | investorshangout | 02/15/2019 10:38:14 PM |
News, Short Squeeze, Breakout and More Instantly...
OncoMed Pharmaceuticals Inc. Company Name:
OMED Stock Symbol:
NASDAQ Market:
OncoMed Pharmaceuticals Inc. Website:
Notice of Preliminary Results THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN. LONDON, April 23, 2019 (GLOBE NEWSWIRE) -- Mereo...
LONDON, April 18, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, announces today that stockholders of OncoMed (NASDAQ: OMED) have approved the transactions contemplated by the merger agreement da...
REDWOOD CITY, Calif., March 15, 2019 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (“OncoMed”) (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that its board of directors declar...